# Gentherm Inc: Form 10-Q for the period ended Mar 31, 2013

- Company: [Gentherm Inc](/companies/thrm.md) (CIK 903129)
- Form: 10-Q
- Filed: 2013-05-09
- Accepted by EDGAR: May 9, 2013, 19:25 ET
- Period: 2013-03-31
- Accession: 0001193125-13-210814
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/903129/000119312513210814/d517575d10q.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/903129/000119312513210814/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2013-03-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2013-01-01 to 2013-03-31 | $148.1m | us-gaap:Revenues |
| Cost of revenue | 3 months, 2013-01-01 to 2013-03-31 | $109.0m | us-gaap:CostOfGoodsSold |
| Gross profit | 3 months, 2013-01-01 to 2013-03-31 | $39.1m | us-gaap:GrossProfit |
| Selling, general and administrative | 3 months, 2013-01-01 to 2013-03-31 | $16.3m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months, 2013-01-01 to 2013-03-31 | $9.8m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months, 2013-01-01 to 2013-03-31 | $795.0k | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2013-01-01 to 2013-03-31 | $8.7m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2013-01-01 to 2013-03-31 | $0.24 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2013-01-01 to 2013-03-31 | $0.24 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2013-01-01 to 2013-03-31 | 32,083,549 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 3 months, 2013-01-01 to 2013-03-31 | $10.0m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months, 2013-01-01 to 2013-03-31 | $6.1m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | at 2013-03-31 | $48.0m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2013-03-31 | $235.7m | us-gaap:AssetsCurrent |
| Total assets | at 2013-03-31 | $427.2m | us-gaap:Assets |
| Current liabilities | at 2013-03-31 | $122.3m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2013-03-31 | $233.4m | us-gaap:Liabilities |
| Shareholders' equity | at 2013-03-31 | $177.6m | us-gaap:StockholdersEquity |

## Management's discussion and analysis

As filed, 18,652 characters.

### General

Gentherm Incorporated designs, develops, manufactures and markets proprietary thermal seat comfort systems and cable systems for sale to automobile and truck original equipment manufacturers (“OEMs”). The Company’s current reportable segments are Climate Controlled Seats (“CCS), Advanced Technology and W.E.T. CCS represents historical Gentherm’s seat climate control systems, which are designed to improve the temperature comfort of automobile passengers. The CCS segment includes sales of our heated and cooled cup holder and heated and cooled mattress, both of which utilize our proprietary thermoelectric device (“TED”) technology.

Advanced Technology represents a division of the Company engaged in research and development efforts to improve the efficiency of TEDs and to develop, market and distribute products based on this technology.

W.E.T., a German publicly traded company based in Odelzhausen, Germany, is a subsidiary of Gentherm. W.E.T.’s primary product categories include automotive seat comfort systems and specialized automotive cable systems. The automotive seat comfort systems category includes automotive seat heaters, climate comfort systems (similar to Gentherm’s climate controlled seat technology) for automotive seats, automotive steering wheel heater systems and integrated electronic components. The specialized automotive cable systems category includes ready-made wire harnesses and related wiring products.

On February 22, 2013, historical Gentherm acquired 442,253 shares in W.E.T., representing approximately 14% of the total outstanding shares in W.E.T., through a transaction agreement with W.E.T.’s largest minority shareholder. The Company paid 3,300,000 shares of Gentherm common stock and cash of €5,408,000 or $7,247,000 for these shares. As of May 7, 2013, we have acquired an additional 308,400 shares in W.E.T., pushing our total ownership interest in W.E.T. above 99%. These additional shares were purchased at a price €85 per share for a total of €26,214,000 or $35,127,000. Gentherm borrowed an additional $40,441,000 from the US Bank of America credit facility in connection with the purchase of these shares. See Note 6 for additional information about the US Bank of America credit facility.

On February 22, 2013, the Company registered a Domination and Profit and Loss Transfer Agreement (“DPLTA”) in Germany with respect to W.E.T. The DPLTA essentially allows historical Gentherm and W.E.T. to be managed as one operational entity.

Management is currently in the process of developing new segments based on future integration plans for W.E.T. and new global strategy.

#### First Quarter 2013 Compared with First Quarter 2012

The following table presents segment information about the reported product revenues and operating income of the Company for the three month period ended March 31, 2013 and 2012. With the exception of goodwill, asset information by segment is not reported since the Company does not manage assets at a segment level at this time. Goodwill as of March 31, 2013 and 2012 pertained entirely to our W.E.T. segment.

*(In Thousands)*

| Three Months Ended March 31, 2013: | CCS | Advanced Technology | W.E.T. | Reconciling Items | Consolidated Total |
| --- | ---: | ---: | ---: | ---: | ---: |
| Product revenues | $32,978 | $— | $115,112 | $— | $148,090 |
| Depreciation and amortization | 333 | 114 | 7,203 | 284 | 7,934 |
| Operating income (loss) | 8,901 | (1,790) | 9,274 | (6,594) | 9,791 |
| 2012: |  |  |  |  |  |
| Product revenues | $28,998 | $— | $100,528 | $— | $129,526 |
| Depreciation and amortization | 287 | 82 | 6,890 | 262 | 7,521 |
| Operating income (loss) | 6,972 | (1,815) | 7,322 | (4,029) | 8,450 |

*Product Revenues*. Product revenues for the three months ended March 31, 2013 (“First Quarter 2013”) were $148,090,000 compared with product revenues of $129,526,000 for the three months ended March 31, 2012 (“First Quarter 2012”), an increase of $18,564,000, or 14%. Product revenues for CCS increased by $3,980,000 or 14% while product revenues for W.E.T. grew by $14,584,000, or 15%, compared to First Quarter 2012. Higher CCS revenue was primarily driven by new program launches since

First Quarter 2012 including the newly redesigned Land Rover Range Rover and additional volume on programs launched during First Quarter 2012 including the Nissan Pathfinder and Infiniti JX. Production volumes on existing vehicle platforms where higher in North America but lower in Japan. The weakness in Japan primarily reflected certain mature vehicle programs that are expected to be refreshed in the coming months. W.E.T. product revenue increases resulted from strong automotive volumes in North America and Asia and due to continued market penetration in the automotive cable business. W.E.T.’s European based sales were slightly higher than the prior year despite local economic weakness partly due to this market penetration. Foreign currency translation of our Euro denominated product revenue for First Quarter 2013, which was approximately €34,900,000 verses €33,100,000 during First Quarter 2012, had only a modest impact on our product revenue results. The average US Dollar/Euro exchange rate for First Quarter 2013 was 1.3207 versus 1.3108 for First Quarter 2012.

*Cost of Sales.* Cost of sales increased to $109,039,000 in First Quarter 2013 from $97,022,000 in First Quarter 2012. This increase of $12,017,000, or 12%, is due to increased sales volume offset by higher gross margin percentages. A favorable change in product mix and greater coverage of fixed costs at the higher volume levels increased historical gross profit percentage during First Quarter 2013 to approximately 26% compared with 25% during First Quarter 2012.

*Net Research and Development Expenses.* Net research and development expenses were $11,841,000 during First Quarter 2013 compared to $10,081,000 in First Quarter 2012, an increase of $1,760,000, or 17%. This increase is primarily driven by additional resources, including personnel, focused on application engineering for new production programs of existing products, development of new products and a program to develop the next generation of seat comfort products using the best ideas and designs of the combined Gentherm and W.E.T. systems. New product development includes automotive heated and cool storage devices, automotive interior thermal management devices, medical thermal management devices, battery thermal management devices and other potential products.

We classify development and prototype costs and related reimbursements as research and development. This is consistent with accounting standards applied in the automotive industry. Depreciation costs for tooling are included in cost of sales.

*Acquisition Transaction Expenses.* We incurred $1,163,000 in fees, legal and other expenses associated with the acquisition of W.E.T. shares during First Quarter 2013. These fees included payments totaling $750,000 to the holders of our Series C Convertible Preferred Stock who waived certain equity offering participation rights allowing for the partial funding of W.E.T. shares with Gentherm common stock. We did not incur any acquisition transaction expenses during First Quarter 2012.

*Selling, General and Administrative Expenses.* Selling, general and administrative expenses increased to $16,256,000 in First Quarter 2013 from $13,973,000 in First Quarter 2012, an increase of $2,283,000, or 16%. This increase in expenses is due to higher general legal, audit and travel costs, as well as wages and benefits costs resulting from new employee hiring and merit increases. The additional employees are primarily related to establishing a new electronics production facility in Shenzhen, China, increasing sales and marketing efforts aimed at supporting our current product development strategy and beginning the integration process between historical Gentherm and W.E.T. We incurred approximately $250,000 in incremental audit and accounting expenses driven by Sarbanes-Oxley compliance implementation for W.E.T. which began during the second quarter of 2012. We believe that our selling, general and administrative costs will begin to level off as we work through the integration process and implement cost reduction initiatives enabled by this integration over the next three years.

*Income Tax Expense.* We recorded an income tax expense of $795,000 during First Quarter 2013 representing an effective tax rate of 7% on earnings before income tax of $10,704,000. This amount included a one-time benefit resulting from the American Taxpayer Relief Act of 2012 (“the Act”) which was signed into law on January 2, 2013. The Act restored the research and development credit and certain exemption under the foreign income tax rules, retroactively to the beginning of 2012. As a result, we recognized approximately $1,300,000 in benefits associated with our 2012 tax year during First Quarter 2013. Had the Act been adopted during 2012, the benefit would have been recorded during that year and First Quarter 2013 effective tax rate would have been 20%. This effective tax rate was lower than the US Federal rate of 34% primarily due to the impact of lower statutory rates for our subsidiaries operating in foreign jurisdictions. During First Quarter 2012, we recorded an income tax expense of $2,145,000 representing an effective tax rate of 26% on earnings before income tax of $8,242,000. Our effective tax rate was estimated based upon a forecast of our full year results.

### Liquidity and Capital Resources

The following table represents our cash and cash equivalents and short-term investments which are available for our business operations:

*(In thousands)*

|  | March 31, 2013 | December 31, 2012 |
| --- | ---: | ---: |
| Cash and cash equivalents | $47,977 | $58,152 |

We manage our cash and cash equivalents in order to fund operating requirements and preserve liquidity to take advantage of future business opportunities. Cash and cash equivalents decreased by $10,175,000 in First Quarter 2013. As of March 31, 2013, the Company had approximately $14,706,000 in cash and cash equivalent at foreign locations. If that cash and cash equivalents were needed for our operations in the U.S. in the future we would be required to accrue and pay U.S. taxes in order to repatriate these funds. Based on our current plans, we believe we have sufficient cash in the U.S. to fund our U.S. operations and our intent is to permanently reinvest these foreign amounts outside of the U.S.

Cash provided by operating activities during First Quarter 2013 was $10,039,000 and was attributable to net income of $9,909,000, net of non-cash adjustments. Non-cash adjustments included depreciation and amortization of $7,934,000, deferred tax benefits of $740,000, gains on revaluation of financial derivatives of $1,244,000 and stock compensation of $491,000.

As of March 31, 2013, working capital was $113,401,000 compared to $124,935,000 at December 31, 2012, a decrease of $11,534,000, or 9%. Decreases in cash and cash equivalents and inventory and an increase to current maturities of long-term debt of $10,175,000, $1,518,000 and $5,291,000, respectively, were partially offset by increases in accounts receivable of $5,701,000. Account receivable increased primarily as a result of timing differences between when sales in First Quarter 2013 were recognized compared with sales recognized during the three months ended December 31, 2012 (“Fourth Quarter 2012”). Gentherm incurred proportionally more sales in the last month of First Quarter 2013 compared with the last month of Fourth Quarter 2012 due to the year-end holiday season. Current maturities of long-term debt increased due to draws made on our US Bank of America Credit Facility to finance the purchase of outstanding shares of W.E.T. held by non-controlling interests. See the General section of Management’s Discussion and Analysis of Financial Condition and Results of Operations for additional information about the acquisition of W.E.T. shares. During First Quarter 2013, cash was used to make payments on our outstanding term notes and Series C Convertible Preferred Stock. Total payments on outstanding borrowings were $5,182,000 and total Series C Convertible Preferred Stock payments were $8,268,000. Working Capital was also impacted by changes in currency exchange rates.

Cash used in investing activities was $46,417,000 during First Quarter 2013, reflecting the purchase of W.E.T. shares from non-controlling interests totaling $40,302,000 and purchases of property and equipment totaling $6,116,000. Purchases of property and equipment for the period are primarily related to expansion of production capacity, as well as replacement of existing equipment.

Cash provided by financing activities was $28,478,000 during First Quarter 2013, reflecting additional borrowings from our US Bank of America Credit Facility of $40,441,000 and proceeds from the exercise of common stock options of $1,487,000. These amounts were partially offset by repayments on our outstanding term notes and Series C Convertible Preferred stock totaling $5,182,000 and $8,268,000, respectively.

Series C Convertible Preferred Stock installments paid during the three month period ended March 31, 2013 are as follows (in thousands, except share data):

|  | Installment Payments ($) |
| --- | ---: |
| Dividend | $488 |
| Principal | 7,780 |
| Total | $8,268 |

In March 2013, holders of the Series C Convertible Preferred Stock elected to covert 165 shares into shares of common stock at the conversion price of $15.83 per share. The Company issued approximately 105,000 shares of common stock related to the conversion of Series C Convertible Preferred Stock.

The Company has two outstanding credit agreements with a syndicate of banks led by Bank of America; the US Bank of America credit facility and the W.E.T. Bank of America credit facility. The US Bank of America credit facility consists of the US Term Note and Europe Term Note. These notes are subject to quarterly principal payments, with total principal amortization of 10% of the original principal amount in the first year and amortization of 12.5%, 15%, 17.5% and 20% of the original principal amount during years two, three, four and five, respectively with all remaining amounts owing under each term facility due and payable in full at the term loan maturity date. The W.E.T. Bank of America credit facility consists of the W.E.T. Term Note, which is subject to quarterly principal payments totaling 20% annually. Principal outstanding under both the US Bank of America credit facility and W.E.T. Bank of America credit facility will be due and payable in full on March 30, 2016. Interest is payable quarterly. The Company has the option to elect interest rates based on either a Eurocurrency (LIBOR or EUIBOR) rate (“Eurocurrency Rate Loans”) (0.20% – 0.40% at March 31, 2013) or a base rate (“Base Rate Loans”) plus a margin (“Applicable Rate”), which varies based on the Consolidated Leverage Ratio of the Company, as defined by the US and W.E.T. Bank of America credit agreements. The base rate is equal to the highest of the Federal Funds Rate (0.09% at March 31, 2013) plus 0.5%, Bank of America’s prime rate (3.25% at March 31, 2013), or a one month Eurocurrency rate plus 1.0%. The Applicable Rate for the current period was 1.75% for Eurocurrency Rate Loans and 0.75% for Base Rate Loans.

We have also borrowed ¥20,000,000, or $3,159,000, from Bank of China to fund a plant expansion project in China. The Bank of China loan is due in lump sum on September 10, 2013 with interest calculated at a fixed rate of 6.9%.

In February 2013, the Company made a $40,441,000 draw on the existing Europe Term Note portion of the US Bank of America credit facility to finance the purchase of shares of WET held by non-controlling interests. The Europe Term Note is now closed and additional draws are not available to Gentherm.

No amounts were outstanding under either the US Revolving Note or the W.E.T. Revolving Note as of March 31, 2013 and $29,550 and €20,000 were available under each note, respectively. Gentherm also has an outstanding Letter of Credit of $450,000 as of March 31, 2013.

The Company must maintain certain financial ratios including a minimum Consolidated Fixed Charge Coverage Ratio and a maximum Leverage Ratio as defined by the Bank of America credit agreement. The loans are secured by all of the Company’s assets.

As of March 31, 2013, we were in compliance with all terms as outlined in the credit agreement for each of the US Bank of America credit facility, the W.E.T. Bank of America credit facility and the Bank of China loan.

The following table summarizes the Company’s debt at March 31, 2013 and December 31, 2012 (in thousands).

|  | March 31,2013 Interest Rate | Principal Balance | December 31, 2012 Principal Balance |
| --- | ---: | ---: | ---: |
| US Term Note | 2.02% | $28,219 | $29,312 |
| Europe Term Note | 2.01% | 43,367 | 4,476 |
| W.E.T. Term Note | 2.00% | 16,603 | 18,852 |
| Bank of China | 6.90% | 3,191 | 3,172 |
| Capital Leases | 5.50% | 443 | 1,140 |
| Total debt |  | 91,823 | 56,952 |
| Current portion |  | (22,509) | (17,218) |
| Long-term debt, less current maturities |  | $69,314 | $39,734 |

The Company has a capital lease agreement with SAP for an enterprise resource planning system whose term runs until May of 2013.

The Company has funded its financial needs from inception primarily through net proceeds received through its initial public offering as well as other equity and debt financing activities. Based on its current operating plan, management believes cash and equivalents at March 31, 2013 along with proceeds from future revenues are sufficient to meet operating needs for the foreseeable future.

### Recent Accounting Pronouncement

#### Comprehensive Income

The Financial Accounting Standards Board (“FASB”) amended ASC 220, “Comprehensive Income,” with ASU 2013-02, “Reporting of Amounts Reclassified Out of Accumulated Other Comprehensive Income,” which requires additional disclosures regarding reclassifications out of accumulated other comprehensive income and is effective for all quarterly and annual reporting periods beginning on or after January 1, 2013. While adoption of ASU 2013-02 did not have an impact on our consolidated condensed financial statements for the three-month period ending March 31, 2013, it is likely to expand our disclosures with regard to items currently reported in accumulated other comprehensive income in future periods.

## Market risk

As filed, 11,153 characters.

We are exposed to market risk from changes in foreign currency exchange rates, short term interest rates and price fluctuations of certain material commodities, such as copper. Market risks for changes in interest rates relate primarily to our debt obligations under our Bank of America credit facilities. Foreign currency exchange risks are attributable to sales to foreign customers not denominated in the seller’s functional currency, foreign plant operations, intercompany indebtedness and purchases from foreign suppliers and include exposures to the European Euro, Mexican Peso, Canadian Dollar, Hungarian Forint and Korean Won. Our subsidiary W.E.T. regularly enters into derivative contracts with the objective of managing its financial and operational exposure arising from this risk by offsetting gains and losses on the underlying exposures with gains and losses on the financial instruments used to hedge them. While W.E.T. continuously monitors the hedging program, derivative positions and hedging strategies and maintains documentation as to the hedging objectives, practices and procedures, W.E.T. has not typically designated its derivatives as hedging instruments for accounting purposes.

In March 2008, W.E.T. entered into a 10 year currency related interest rate swap (“CRS”) having a notional value of €10,000,000 or $12,816,000 as of March 31, 2013, in order to offset the interest rate risk associated with a debt financing which was repaid prior to our acquisition of W.E.T. Under this agreement W.E.T. receives interest equal to the then six month Euro Interbank Offered Rate (“EURIBOR”), 0.34% at March 31, 2013, plus 1.40% and pays interest equal to the six month EURIBOR when the exchange rate between the European Euro (“EUR”) and the Swiss Franc (“CHF”), which was 1.22 at March 31, 2013, equals or exceeds 1.46 EUR to the CHF or pays interest equal to the six month EURIBOR plus a premium when this exchange rate is less than 1.46. The premium is calculated as \[(1.46 – current EUR/CHF rate)/current EUR/CHF rate\] x 100. W.E.T. has entered into offsetting derivative contracts designed to cancel out the payment due under the CRS through the end of the CRS agreement, in 2018.

In September 2011, W.E.T. brought a lawsuit against UniCredit Bank AG (“UniCredit”), a past financial advisor, stemming from the recommendation to invest in the aforementioned CRS. On March 25, 2013, the Munich District Court in Munich, Germany ruled in favor of W.E.T., asserting that UniCredit violated its duty to properly advise W.E.T. with respect to the initial negative market value for the CRS and UniCredit’s inherent conflict of interest in recommending that W.E.T. invest in CRS. The Munich District Court ruled that UniCredit must (1) pay €144,000 to W.E.T. and (2) bear the costs of all future obligations under the CRS, which were €10,179,000, or $13,045,000 as of March 31, 2013, plus additional accrued liabilities for past due payments under the CRS of approximately €4,000,000, or $5,126,000 as of March 31, 2013. The Company expects that UniCredit will appeal the decision. If the decision is appealed, it may take up to several years until a final, non-appealable decision is rendered. As a result, the Company cannot be certain that any portion of the award by the Munich District Court will be realized by W.E.T.

In July 2011, the Company entered into a series of interest rate swap contracts designated as cash flow hedges and an interest rate cap agreement in order to hedge the exposure to variable market interest rates on the Company’s senior debt. Gains and losses reported in accumulated other comprehensive income will be reclassified to earnings once the Company’s senior debt is repaid. Information on the interest rate swap contracts is as follows:

| Contract Type | Contract Term | (in thousands) Notional Value | Hedged Instruments | Fixed Rate | Variable Rate | Rate Cap |
| --- | --- | ---: | --- | ---: | --- | ---: |
| Swap | June 30, 2014 | $8,000 | US Term Note | 1.27% | 3 month LIBOR | — |
| Swap | June 30, 2014 | $8,000 | US Term Note | 1.27% | 3 month LIBOR | — |
| Cap | March 31, 2016 | €14,250 | W.E.T. Term Note | — | 3 month EURIBOR | 2.75 |

20

The Company uses a market approach to value derivative instruments, analyzing observable benchmark rates at commonly quoted intervals for the instrument’s full term. Information related to the fair values of derivative instruments in our consolidated balance sheet as of March 31, 2013 is as follows (in thousands):

|  | Hedge Designation | Fair Value Hierarchy | Asset Derivatives Balance Sheet Location | Fair Value | Liability Derivatives Balance Sheet Location | Fair Value | Net Asset/ (Liabilities) |
| --- | --- | --- | --- | ---: | --- | ---: | ---: |
| CRS | Not a hedge | Level 2 |  |  | Current liabilities | $(2,435) |  |
|  |  |  |  |  | Non current liabilities | (10,610) |  |
| Total CRS |  |  |  |  |  | $(13,045) | $(13,045) |
| Foreign currency derivatives | Not a hedge | Level 2 | Current assets | $2 | Current liabilities | $(453) | $(451) |
| Foreign currency derivatives | Not a hedge | Level 2 | Current assets | $146 |  |  | $146 |
|  |  |  | Non current assets | 2,865 |  |  | $2,865 |
| Total foreign currency derivatives |  |  |  | $3,013 |  | $(453) | $2,560 |
| Interest rate swap derivatives | Cash flow hedge | Level 2 |  |  | Current liabilities | $(185) | $(185) |

Information related to the effect of derivative instruments on our consolidated income statements is as follows (in thousands):

|  | Location | Three Months Ended March 31, 2013 | Three Months Ended March 31, 2012 |
| --- | --- | ---: | ---: |
| Foreign currency derivatives | Revaluation of derivatives | $(974) | $1,087 |
|  | Foreign currency gain (loss) | (291) | 897 |
| Total foreign currency derivatives |  | $(1,265) | $1,984 |
| CRS | Revaluation of derivatives | $1,320 | $147 |
| Commodity derivatives | Revaluation of derivatives | $— | $126 |
| Interest Rate Swap | Interest Expense | $(1) | $(28) |
|  | Other Comprehensive Income | $39 | $(33) |

We did not incur any hedge ineffectiveness during the three months ended March 31, 2013 and 2012.

#### Interest Rate Sensitivity

The table below provides information about the Company’s debt obligations, derivative financial instruments and other financial instruments that are sensitive to changes in interest rates. For debt and capital lease obligations, the table presents principal cash flows and related weighted average interest rates by expected maturity dates. For interest rate swaps, the table presents notional amounts and weighted average interest rates by expected (contractual) maturity dates. Notional amounts are used to calculate the contractual payments to be exchanged under the contract. Weighted average variable rates are based on implied forward rates in the yield curve at the reporting date. The information is presented in U.S. dollar equivalents, which is the Company’s reporting currency. The instruments actual cash flows are denominated in both U.S. dollars ($USD) and European Euros (€EUR), as indicated in parentheses.

### March 31, 2013

*(In Thousands except rate information)*

| Liabilities Long Term Debt: | Expected Maturity Date 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | Total | Fair Value |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Fixed Rate (€EUR) | $443 | $— | $— | $— | $— | $— | $— | $443 | $443 |
| Average Interest Rate | 5.50% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 5.50% |  |
| Fixed Rate (¥CNY) | $3,191 | $— | $— | $— | $— | $— | $— | $3,191 | $3,165 |
| Average Interest Rate | 6.90% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 6.90% |  |
| Variable Rate ($USD) | $9,702 | $13,874 | $14,578 | $38,229 | $— | $— | $— | $76,383 | $76,383 |
| Average Interest Rate | 2.02% | 2.02% | 2.02% | 2.02% | 0.00% | 0.00% | 0.00% | 2.02% |  |
| Variable Rate (€EUR) | $4,416 | $4,193 | $559 | $2,638 | $— | $— | $— | $11,806 | $11,806 |
| Average Interest Rate | 1.92% | 1.92% | 1.92% | 1.92% | 0.00% | 0.00% | 0.00% | 1.92% |  |
| Derivative Financial Instruments: |  |  |  |  |  |  |  |  |  |
| Interest Rate Swap ($USD) | $75 | $17 | $— | $— | $— | $— | $— | $92 | $92 |
| Average Interest Rate | 0.35% | 0.42% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.36% |  |
| Interest Rate Swap ($USD) | $37 | $75 | $— | $— | $— | $— | $— | $92 | $92 |
| Average Interest Rate | 0.34% | 0.40% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.35% |  |
| Interest Rate Cap (€EUR) | $— | $— | $— | $2 | $— | $— | $— | $2 | $2 |
| Average Interest Rate | 0.00% | 0.00% | 0.00% | 2.75% | 0.00% | 0.00% | 0.00% | 2.75% |  |

22

#### Exchange Rate Sensitivity

The table below provides information about the Company’s derivative financial instruments and other financial instruments by functional currency and presents such information in U.S. dollar equivalents. The table summarizes information on instruments and transactions and are sensitive to foreign currency exchange rates, including foreign currency forward exchange agreements, €EUR denominated debt obligations. For debt obligations, the table presents principal cash flows and related weighted average interest rates by expected maturity dates. For foreign currency forward exchange agreements, the table presents the notional amounts and weighted average exchange rates by expected (contractual) maturity dates. These notional amounts generally are used to calculate the contractual payments to be exchanged under the contract.

### March 31, 2013

*(In Thousands except rate information)*

| Anticipated Transactions And Related Derivatives Euro functional currency Forward Exchange Agreements: (Receive USD$/Pay EUR€) | Expected Maturity or Transaction Date 2013 | 2014 | 2015 | 2016 | 2017 | Thereafter | Total | Fair Value |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Total Contract Amount(€) | €3,796 |  |  |  |  |  | €3,796 | €(282) |
| Average Contract Rate | 1.3769 | — | — | — | — | — | 1.3769 |  |
| (Receive HUF/Pay EUR€) |  |  |  |  |  |  |  |  |
| Total Contract Amount (€) | €1,989 |  |  |  |  |  | €1,989 | €(24) |
| Average Contract Rate | 301.66 | — | — | — | — | — | 301.66 |  |
| (Receive CHF/Pay EUR) |  |  |  |  |  |  |  |  |
| Total Contract Amount (€) | €6,185 | €12,336 | €12,335 | €12,437 | €12,302 | €6,151 | €61,746 | €2,344 |
| Average Contract Rate | 1.20 | 1.20 | 1.20 | 1.20 | 1.20 | 1.20 | 1.20 |  |
| (Receive KRW/Pay EUR€) |  |  |  |  |  |  |  |  |
| Total Contract Amount (€) | €2,263 |  |  |  |  |  | €2,263 | €(42) |
| Average Contract Rate | 1,458.45 | — | — | — | — | — | 1,458.45 |  |
| **$US functional currency** |  |  |  |  |  |  |  |  |
| **Forward Exchange Agreements:** |  |  |  |  |  |  |  |  |
| (Receive USD$/Pay CAD$) |  |  |  |  |  |  |  |  |
| Total Contract Amount ($) | $2,551 |  |  |  |  |  | $2,551 | $5 |
| Average Contract Rate | 1.0155 | — | — | — | — | — | 1.0155 |  |
| (Receive USD$/Pay MXN) |  |  |  |  |  |  |  |  |
| Total Contract Amount ($) | $803 |  |  |  |  |  | $803 | $7 |
| Average Contract Rate | 12.4525 | — | — | — | — | — | 12.4525 |  |

23

## Controls and procedures

As filed, 2,665 characters.

### (a) Evaluation of Disclosure Controls and Procedures

Our management has evaluated, with the participation of our principal executive and principal financial officers, the effectiveness of our disclosure controls and procedures and of our internal control over financial reporting, both as of March 31, 2013. Based on their evaluation, our principal executive and principal financial officers have concluded that these controls and procedures are effective as of March 31, 2013.

Disclosure controls and procedures and other procedures are designed to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the Securities and Exchange Commission’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is accumulated and communicated to our management, including our principal executive and principal financial officers, as appropriate to allow timely decisions regarding required disclosure.

Internal control over financial reporting is a process designed by, or under the supervision of, our principal executive and principal financial officers, and effected by our board of directors, management and other personnel, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles and includes those policies and procedures that: (1) pertain to the maintenance of records that in reasonable detail accurately and fairly reflect our transactions and dispositions of assets, (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that our receipts and expenditures are being made only in accordance with authorizations of our management and directors, and (3) and provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of our assets that could have a material effect on the financial statements.

### (b) Changes in Internal Control over Financial Reporting

During the fiscal quarter ended March 31, 2013, there was no change in our internal control over financial reporting that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

## Risk factors

As filed, 146 characters.

There were no material changes in our risk factors previously disclosed in Part I, Item 1A. of our Form 10-K for the year ended December 31, 2012.

Filed May 9, 2013.
Source: SEC EDGAR, the filing index for accession 0001193125-13-210814. Last ingested by Listed: Oct 26, 2026, 17:44 ET. No prices; not investment advice.
